Related Experiment Video
Updated: Jun 12, 2026

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
Published on: June 9, 2018
First Japanese Case of Hereditary Transthyretin Amyloid Cardiomyopathy with an Ile68Leu Variant: A Case Report
Junya Tanabe1, Yuki Kawashima-Sonoyama2,3, Momoko Araki3
1Department of Cardiology, Shimane University Hospital, Japan.
Transthyretin amyloid cardiomyopathy (ATTR-CM) is increasingly recognized because of improved diagnostic modalities and disease-modifying therapy. We report the first Japanese case of hereditary ATTR-CM (ATTRv-CM) caused by the Ile68Leu variant, which has been previously described in European cohorts. A man in his 40s presented with heart failure and typical imaging findings of transthyretin amyloid cardiomyopathy (ATTR-CM). Genetic testing identified the Ile68Leu variant, which was absent in East Asian population databases. This case expands the genetic spectrum of ATTRv-CM in Japan and suggests that cardiac-predominant non-Val30Met TTR variants may occur in Japanese patients, with implications for the diagnosis, family counseling, and cascade screening in the future.
Transthyretin amyloid cardiomyopathy (ATTR-CM) is increasingly recognized because of improved diagnostic modalities and disease-modifying therapy. We report the first Japanese case of hereditary ATTR-CM (ATTRv-CM) caused by the Ile68Leu variant, which has been previously described in European cohorts. A man in his 40s presented with heart failure and typical imaging findings of transthyretin amyloid cardiomyopathy (ATTR-CM). Genetic testing identified the Ile68Leu variant, which was absent in East Asian population databases. This case expands the genetic spectrum of ATTRv-CM in Japan and suggests that cardiac-predominant non-Val30Met TTR variants may occur in Japanese patients, with implications for the diagnosis, family counseling, and cascade screening in the future.
Related Concept Videos
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Huntington Disease l: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy

